Intravitreal Triamcinolone Acetonide in Diabetic Macular Edema
Abstract: Diabetic retinopathy (DR) is the most common microvascular complication of diabetes. The most common cause of vision loss in diabetic retinopathy is diabetic macular edema. Intravitreal injection of corticosteroids (triamcinolone acetonide), constitutes a newer, less destructive treatment modality in the management of diabetic macular edema. . Intravitreal triamcinolone acetonide is a favourable and promising therapeutic tool in managing diffuse diabetic macular oedema for certain duration of time with minimal transient side effect.
Keywords: Diabetic macular edema, OCT, intravitreal triamcinolone acetonide
How to Cite?: Dr. Kabita Bora Baishya, Dr. Suprio Kumar Datta, "Intravitreal Triamcinolone Acetonide in Diabetic Macular Edema", Volume 7 Issue 10, October 2018, International Journal of Science and Research (IJSR), Pages: 915-919, https://www.ijsr.net/getabstract.php?paperid=ART20192017, DOI: https://dx.doi.org/10.21275/ART20192017